Concerns Over NIH Funding Distribution

The Trump administration has pinpointed the National Institutes of Health (NIH) as a significant focus, and there are reasons for that. Although the NIH has a critical mission, it appears to have been co-opted for political purposes.

NIH research grants tend to be highly concentrated in a limited number of congressional districts, particularly those represented by progressive lawmakers. In fact, in 2024, more than half of NIH grants were awarded to just 20 districts, all of which are situated in liberal areas.

Typically, these grants are awarded through a competitive process judged by committees of experts. However, gaining a position on these committees or being seen as an expert often depends on having previously received federal funding.

This creates a somewhat insular group of researchers at a few universities who end up redistributing funds among themselves. If researchers outside this closed circle start securing substantial grants, the universities’ high overhead costs can incentivize them to offer these researchers attractive salaries to entice them into their favored institutions.

Utilizing taxpayer money to support such a narrow group for health research, which is perceived to be predominantly liberal, raises questions about political bias and undermines trust in the findings, all while driving up costs.

First off, the concentration of these researchers influences the topics they choose to investigate.

For instance, a look at the NIH’s website shows that, over the past decade, there have been 71,482 projects related to diversity. In comparison, only 47,018 projects focused on obesity, which remains a critical public health issue, affecting a significant portion of the adult and child population.

Furthermore, the NIH’s records highlight 2,735 projects related to transgender issues in the last decade, compared to just 19 that examined the health impacts of prayer.

This skewed focus in health research is diminishing public trust in the NIH and in scientific research as a whole.

A recent survey indicates that merely 22% of respondents express “a great deal of trust” in NIH scientists, particularly among Republican participants, trust levels seem notably lower. With much of the research conducted in elite coastal areas, confidence that these researchers are attuned to everyday Americans’ concerns isn’t exactly bolstered.

On top of that, concentrating research leads to higher costs for taxpayers.

Universities impose overhead charges on research grants, which cover administrative and facility expenses. These charges vary based on the local cost of living and the universities’ strategies to maximize their funding. Interestingly, the institutions benefiting most from NIH grants also happen to have the highest overhead rates—often due to their locations in costly cities and their ability to charge more.

For example, Harvard charges an overhead rate of 69%, meaning that for each dollar the NIH allocates for research, taxpayers owe an additional 69 cents just for overhead. Yale’s rate is around 67.5%, while Cal Tech charges 68.4%.

In contrast, universities receiving minimal NIH funding charge much lower overhead rates. The University of Mississippi, for instance, only charges 46%, whereas the University of North Dakota charges 41%.

Considering economies of scale—where the overhead costs per project typically decrease as they’re spread over more projects—it doesn’t quite add up that research in high-grant institutions should cost more than in those that receive fewer funds. It also doesn’t make sense for taxpayers to face higher charges when most research is concentrated in expensive locales. There’s no obvious reason why scientists can’t conduct their work in states like Mississippi or North Dakota instead of in Boston or Los Angeles.

The uneven geographical distribution of government funding, including in scientific fields, carries significant political implications. Most government agencies wisely avoid funneling all their resources into a few locations. Instead, they distribute their spending broadly, recognizing that this approach aids in controlling costs, enhancing trust in government initiatives, and ensuring various perspectives are represented across the country.

The NIH would do well to learn from this and adopt a similar strategy.